Skip to main content
Clinical Trials/NCT02969161
NCT02969161CompletedNot Applicable

Safe Generations Plus: Mother Infant Retention Across the Option B-plus Cascade

Columbia University10 sites in 1 country616 target enrollmentStarted: March 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
616
Locations
10
Primary Endpoint
Proportion of patients who are retained in care

Study Overview

Brief Summary

This study is to understand how to improve retention in care and treatment services to HIV positive pregnant women and their babies in Swaziland. The investigators will evaluate outcomes of patients who are lost-to-follow-up (LTF) under a new approach for prevention of mother-to-child (PMTCT) called Option B+, where all HIV positive pregnant women initiate lifelong antiretroviral therapy (ART) regardless of their disease stage. The goal is to understand the outcomes of patients who are LTF from care, and the reasons for disengagement from care in the context of PMTCT in order to inform efforts to improve retention in care among patients under Option B+.

Detailed Description

The study will be conducted among approximately 1,600 women and their infants who received Option B+ PMTCT services at ten facilities in Swaziland. These facilities were included in another study on Option B+ called Safe Generations in which routinely collected patient-level data was abstracted from medical registers. This study has three parts: the first is a review of alternative patient medical records among women and their infants who were documented as LTF in the Safe Generations study. The second component consists of tracing women who are LTF on the phone or in the community to administer a questionnaire. Lastly, an in-depth interview will be conducted among a sub-group of women to explore patterns of care.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
1 Year to 50 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Mothers and their infants who were enrolled in PMTCT at Safe Generations study sites after the sites transitioned to Option B+.
  • Determined to be LTF per the Safe Generations study protocol (i.e., have not attended a clinic visit in the 90 days prior to their 6-month postpartum appointment and are not known to be dead or transferred out, according to clinical visit data abstracted to the Safe Generations study database).

Exclusion Criteria

  • Mothers that are not a PMTCT client.

Outcomes

Primary Outcomes

Proportion of patients who are retained in care

Time Frame: Up to 24 months

Confirmation of retained status among all Option B+ mothers and their infants who are identified as LTF per the Safe Generations study through review of facility-based records - to determine maternal reasons for leaving care.

Secondary Outcomes

  • Proportion of patients who have died(Up to 24 months)
  • Proportion of patients who have disengaged from care entirely(Up to 24 months)
  • Proportion of patients who are in care at another facility(Up to 24 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

William Reidy

Associate Research Scientist, ICAP

Columbia University

Study Sites (10)

Loading locations...

Similar Trials

Safe Generations Plus: Swaziland PMTCT LTF... | Clinical Trial